IQ Solutions has been awarded a 2-year, multi-faceted contract to help Combat COVID. With this contract, the company supports Combat COVID (https://CombatCOVID.hhs.gov), a one-stop resource from the U.S. Department of Health and Human Services for current, evidence-based information on COVID-19 vaccines, treatments, and clinical trials for treatments. Combat COVID also offers helplines in English and Spanish to assist callers who want to learn more about participating in clinical trials for treatments and about monoclonal antibody therapeutics for COVID-19.
The clinical trials featured on Combat COVID are supported by Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), a public-private partnership coordinating a research strategy to prioritize and speed development of the most promising treatments and vaccines for COVID-19. The ACTIV initiative was launched by the National Institutes of Health and aims to reduce national morbidity and mortality resulting from the worst worldwide pandemic in over 100 years.
IQ Solutions has been tasked with communications, multicultural outreach, community engagement, media planning and implementation, and digital development and enhancement for Combat COVID and individual ACTIV clinical trials. The goal is to significantly increase participation in clinical trials for people recently diagnosed with COVID-19—including inclusion of underserved populations who have been disproportionately impacted by COVID-19.
The communications messages are far reaching, providing clear and consistent guidance to all, but they place specific emphasis on outreach to key minority communities. Areas of study include:
- COVID-19 positive patients and their loved ones (non-hospitalized)
- COVID-19 positive patients and their loved ones (hospitalized)
- Those exposed to COVID-19 but who have not developed the disease
- Healthcare providers
In less than 12 weeks, we have garnered over 10.7 million impressions, nearly 225,000 ad clicks, and just under 4 million page views on the Combat COVID website through paid and earned media. We have also secured speaking and interview opportunities with the Congressional Black Caucus, Healthcare Provider Organizations Serving People of Color, the Black Coalition Against COVID-19, Allergy & Asthma Network, Telemundo, and Medscape for key federal representatives to talk about the importance of Combat COVID and clinical trials for COVID-19 treatments.
“IQ Solutions is thrilled to be working with the federal government on this priority public health initiative. Putting an end to this pandemic truly takes a nation. We are committed to using the latest scientific research findings to help get accurate and timely information to the public and healthcare professionals,” said Ileana Quintas, CEO and founder of IQ Solutions.